<div id="readability-page-1"><p>Sera Prognostics, Inc. (NASDAQ:SERA - Get Free Report) CEO Zhenya Lindgardt sold 4,155 shares of the stock in a transaction dated Wednesday, December 10th. The shares were sold at an average price of $3.31, for a total transaction of $13,753.05. Following the completion of the transaction, the chief executive officer owned 763,926 shares of the company's stock, valued at $2,528,595.06. This represents a 0.54% decrease in their position. The sale was disclosed in a filing with the Securities &amp; Exchange Commission, which is available through this hyperlink.</p><p>Zhenya Lindgardt also recently made the following trade(s): </p><ul><li>On Tuesday, December 9th, Zhenya Lindgardt sold 28,215 shares of Sera Prognostics stock. The stock was sold at an average price of $3.04, for a total transaction of $85,773.60. </li></ul><div><p><span></span><span>Get <strong>Sera Prognostics</strong> alerts:</span></p></div><h2>Sera Prognostics Price Performance</h2><p>Shares of NASDAQ:SERA remained flat at $3.40 during trading on Thursday. 48,874 shares of the stock were exchanged, compared to its average volume of 34,279. The business's fifty day moving average is $3.18 and its two-hundred day moving average is $2.79. The firm has a market cap of $131.24 million, a price-to-earnings ratio of -4.42 and a beta of 0.97. Sera Prognostics, Inc. has a 12 month low of $1.37 and a 12 month high of $9.13. </p><p>Sera Prognostics (NASDAQ:SERA - Get Free Report) last posted its quarterly earnings data on Thursday, November 13th. The company reported ($0.16) EPS for the quarter, beating analysts' consensus estimates of ($0.19) by $0.03. The business had revenue of $0.02 million for the quarter, compared to analyst estimates of $0.10 million. Sera Prognostics had a negative net margin of 34,343.16% and a negative return on equity of 41.69%.  On average, research analysts forecast that  Sera Prognostics, Inc. will post -0.96 EPS for the current year. </p><h2>Institutional Trading of Sera Prognostics</h2><p>A number of hedge funds have recently bought and sold shares of SERA. XTX Topco Ltd acquired a new position in shares of  Sera Prognostics in the first quarter worth about $39,000.  Nuveen LLC purchased a new stake in shares of  Sera Prognostics in the 1st quarter valued at approximately $138,000.  Aberdeen Group plc purchased a new stake in shares of  Sera Prognostics in the 1st quarter valued at approximately $4,563,000.  Ghisallo Capital Management LLC acquired a new position in  Sera Prognostics in the 1st quarter worth approximately $368,000.  Finally, Baker BROS. Advisors LP grew its position in  Sera Prognostics by 1.2% during the 1st quarter. Baker BROS. Advisors LP now owns 5,498,170 shares of the company's stock worth $20,233,000 after purchasing an additional 63,771 shares in the last quarter. 54.64% of the stock is owned by hedge funds and other institutional investors. </p><h2>Analyst Upgrades and Downgrades</h2><p>A number of analysts have recently commented on SERA shares. Weiss Ratings  reissued a &#34;sell (d-)&#34; rating on shares of Sera Prognostics in a research note on Monday. Wall Street Zen raised Sera Prognostics from a &#34;sell&#34; rating to a &#34;hold&#34; rating in a report on Saturday, October 25th. One investment analyst  has rated the stock with a Sell rating,  According to data from MarketBeat.com, the stock  has an average rating of &#34;Sell&#34;.</p><p><b>Read Our Latest Report on Sera Prognostics</b></p><h2>About Sera Prognostics</h2> (Get Free Report)<p>Sera Prognostics, Inc, a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes in the United States. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies.</p><h2>Further Reading</h2><ul><li>Five stocks we like better than Sera Prognostics</li><li>5 Top Rated Dividend Stocks to Consider</li><li>3 Recently Downgraded Stocks to Avoid in 2026</li><li>How to Invest in Biotech Stocks</li><li>The Chip Boom Is Back: 3 Stocks Positioned for Huge Gains</li><li>What is MarketRank™? How to Use it</li><li>Oracle Stock Hit Hard: Why Its AI Pipeline Could Drive a 2026 Rally</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9U0VSQQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9U0VSQQ"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Sera Prognostics Right Now?</h2><p>Before you consider Sera Prognostics, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sera Prognostics wasn't on the list.</p><p>While Sera Prognostics currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

SERA

<p>Sera Prognostics CEO Zhenya Lindgardt sold 4,155 shares at $3.31 each, totaling $13,753.05, reducing her ownership by 0.54%. The transaction was disclosed to the SEC. Previously, she sold 28,215 shares at $3.04 each. Sera Prognostics' stock remained flat at $3.40, with a market cap of $131.24 million. The company reported a quarterly EPS of ($0.16), beating estimates. Hedge funds own 54.64% of the stock. Analysts have mixed ratings, with a recent upgrade from 'sell' to 'hold.'</p>

Sera Prognostics (NASDAQ:SERA) CEO Zhenya Lindgardt Sells 4,155 Shares